遺伝子改変マウスを用いる短期がん原性試験の現状と有用性  -製薬協アンケート調査および文献調査の報告-

河野 茂生; 加藤 直樹; 高木 広憲; 西田 仁; 安木 大策; 堀籠 博亮; 佐村 恵治; 久田 茂; 木村 敬; 永山 隆; 山口 俊哉; 木幡 信彦; 細井 一弘; 小林 章男; 日浦 政則; 古川 浩美; 水間 秀行; 中村 和市; 佐神 文郎; 三分一所 厚司

doi:10.14869/toxp.36.0.4044.0

The 36th Annual Meeting of the Japanese Society of Toxicology

Session ID : P-44

DOI https://doi.org/10.14869/toxp.36.0.4044.0

Conference information

Host: The Japanese Society of Toxicology

Organ Toxicity, Metabolism, Method, etc.

Current Status of Short-term Carcinogenicity Study Using Genetically-engineered Mice -Questionnaire Survey and Literature Research of Japan Pharmaceutical Manufacturers Association-

*Shigeo KAWANO, Naoki KATO, Hironori TAKAGI, Hitoshi NISHIDA, Daisaku YASUGI, Hiroaki HORIGOME, Keiji SAMURA, Shigeru HISADA, Takashi KIMURA, Takashi NAGAYAMA, Toshiya YAMAGUCHI, Nobuhiko KOWATA, Kazuhiro HOSOI, Akio KOBAYASHI, Masanori HIURA, Hiromi FURUKAWA, Hideyuki MIZUMA, Kazuichi Nakamura, Fumio SAGAMI, Atsushi SANBUISSHO

Author information

*Shigeo KAWANO
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Naoki KATO
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Hironori TAKAGI
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Hitoshi NISHIDA
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Daisaku YASUGI
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Hiroaki HORIGOME
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Keiji SAMURA
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Shigeru HISADA
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Takashi KIMURA
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Takashi NAGAYAMA
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Toshiya YAMAGUCHI
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Nobuhiko KOWATA
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Kazuhiro HOSOI
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Akio KOBAYASHI
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Masanori HIURA
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Hiromi FURUKAWA
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Hideyuki MIZUMA
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Kazuichi Nakamura
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Fumio SAGAMI
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-
Atsushi SANBUISSHO
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association-

Keywords: genetically-engineered mouse, short-term carcinogenicity study, rasH2 transgenic mouse

CONFERENCE PROCEEDINGS FREE ACCESS

Details

Corresponding author

Register with J-STAGE for free!